Vijaya Diagnostic Centre announced a robust performance for Q3 FY26, delivering 21.4% YoY revenue growth, driven by a ~15% volume growth. Revenue surpassed Q2 figures despite seasonal softness. The company commissioned four new hub centers across West Bengal, Nandyal, and Khammam. Leadership was strengthened with the hiring of a new CFO, CTO, and COO to support future expansion plans.
Q3 FY26 Financial Performance Snapshot
Vijaya Diagnostic Centre reported strong financial results for the third quarter of the financial year ending December 31, 2025 (Q3 FY26). Revenue from Operations stood at INR 2,052 Million, marking a significant 21.4% Year-over-Year (YoY) growth. The company maintained healthy profitability metrics, with EBITDA reaching INR 861 Million (41.9% margin) and PAT at INR 432 Million (21.0% margin).
For the nine months ending December 31, 2025 (9M FY26), Revenue from Operations was INR 5,948 Million (17.1% YoY growth). EBITDA for 9M FY26 was INR 2,414 Million (40.6% margin), and PAT was INR 1,251 Million (21.0% margin).
Key Operational Highlights (Q3 FY26)
Operational scale continued to increase, supporting revenue growth:
- Footfall: Increased to 1.17 Million.
- Tests Performed: Reached 4.22 Million.
- Centres: Total network size stood at 162 centres.
- B2C Focus: B2C Revenue remained high at 92% of the total.
- Wellness Share: The Wellness Share was reported at 14.7%.
Revenue per Test in Q3 FY26 was INR 487, an increase from INR 471 in Q2 FY26.
Geographical Revenue Contribution
The geographical revenue mix highlights the core strength of the business, although diversification efforts are underway:
- Hyderabad: Contributed 68% of the revenue in Q3 FY26.
- RoAPT (Rest of AP & Telangana): Contributed 19%.
- Pune & Kolkata: Each contributed 6% and 3%, respectively.
Management Commentary and Strategic Moves
Ms. Suprita Reddy, MD & CEO, noted the robust Q3 performance, overcoming traditional seasonal softness. Key developments driving future growth include:
- Leadership Expansion: Strengthened the team with the addition of a new CFO (Ankit Shah), CTO (Sai Prasad), and the rejoining of Sivaramaraju Vegesna as COO.
- West Bengal Hub Expansion: Commissioned two state-of-the-art hubs in Phoolbagan and Diamond Harbour in December 2025, establishing a footprint of seven hubs in the state. Both Q1 FY26 West Bengal centers achieved break-even ahead of schedule.
- Core Market Deepening: Launched hubs in Nandyal (AP) and Khammam (Telangana) in October 2025 to broaden presence in Tier 2/3 geographies.
Future Expansion Pipeline
The company is committed to strategic network expansion targeting H1 FY27 commencement:
- Hyderabad: Planning 5 Spokes in H1 FY27 (1 Spoke targeted for H2 FY26).
- RoAPT: Planning 3 Spokes in H1 FY27.
- Bengaluru: Planning 1 Hub and 10 Spokes in H1 FY27 (2 hubs already operational in Q1 FY26).
- West Bengal: Planning 1 Spoke in H1 FY27.
Technical Capabilities and Legacy
Vijaya operates the largest integrated B2C focused diagnostic chain in India, boasting over 40+ years of vintage. The operational infrastructure includes 162 centres across 27 cities and towns, supported by 17 NABL accredited labs. The company utilizes advanced technology, including transitioning to AI Radiology Software “Augmento” in FY24, ensuring high-quality service delivery and competitive Turn-Around Times (TAT).
Source: BSE
